Views 268
Citations 0
Comment & Response
October 2, 2013

Mortality Reporting and Pay-for-Performance Programs—Reply

Author Affiliations
  • 1Department of Cardiology, Methodist Medical Center, Peoria, Illinois

Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2013;310(13):1405. doi:10.1001/jama.2013.277987

In Reply I agree with Dr Bourque and colleagues that current methods of risk adjustment are imperfect and that prolonging life-sustaining measures in patients with little or no likelihood of recovery can be harmful. In contrast, I disagree that the inclusion of 30-day mortality data in hospital value–based purchasing will result in underuse of hospice services. A recent survey of Medicare beneficiaries indicates an increase in hospice use at the time of death.1 Regardless of the specific effect, I am in agreement with Bourque et al that incentivizing specific outcomes has the potential to influence physician behavior and health care delivery.

First Page Preview View Large
First page PDF preview
First page PDF preview